Short-term Prognostic Value of Heart Failure Diagnosis in a Contemporary Cohort of Patients With Adult Congenital Heart Disease

Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study

BACKGROUND

Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). This study aimed to evaluate the temporal relationship between AA and HF onset, the association between HF and the success of radiofrequency ablation (RFA), and how HF influences outcomes in patients with AA.

METHODS

In this single-centre retrospective cohort study, data from 3995 patients with ACHD were analysed. Dates of first AA and HF presentations were documented, and outcomes of RFA, including acute and long-term success, were assessed. All-cause mortality was compared between patients with AA and those with both AA and HF.

RESULTS

The median age at last follow-up was 33 years (IQR 26-42). AA was observed in 348 patients (8.7%), and HF in 256 (6.4%). Among patients who developed both AA and HF (n=130), AA preceded HF in 79% of cases, with a median interval of 6 years (IQR 2-13) before HF diagnosis. In the remaining cases, AA occurred after HF diagnosis (median 2 years, IQR 1-6). RFA was performed in 119 patients (34.2%), 45 of whom had HF. Two years after RFA, 72% of patients were free from AA recurrence. Patients without HF had higher acute success rates (98% vs 90%) and lower recurrence rates (48% vs 76%) than those with HF. Patients with AA with HF had worse overall survival compared with those without HF.

CONCLUSIONS

In patients with ACHD, AA frequently precedes HF by several years. RFA can be an effective treatment for AA, but acute success is lower and recurrence rate higher when HF is present.

Cardiovascular disease risk factors in congenital heart disease survivors are associated with heart failure

BACKGROUND

Despite advances in treatment and survival, individuals with congenital heart defects (CHD) have a higher risk of heart failure (HF) compared to the general population.

OBJECTIVE

To evaluate comorbidities associated with HF in patients with CHD with a goal of identifying potentially modifiable risk factors that may reduce HF-associated morbidity and mortality.

METHODS

Five surveillance sites in the United States linked population-based healthcare data and vital records. Individuals with an ICD-9-CM code for CHD aged 11-64 years were included and were stratified by presence of HF diagnosis code. Prevalence of death and cardiovascular risk factors based on diagnosis codes were compared by HF status using log-linear regression.

RESULTS

A total of 25,343 individuals met inclusion/exclusion criteria. HF was documented for 2.2% of adolescents and 12.9% of adults with CHD. Adolescents and adults with HF had a higher mortality than those without HF. In both age groups, HF was positively associated with coronary artery disease, hypertension, obesity, diabetes, and increased healthcare utilization compared to those without HF.

CONCLUSIONS

Within this population-based cohort, over 1 in 50 adolescents and 1 in 8 adults with CHD had HF, which was associated with increased mortality. Modifiable cardiovascular comorbidities were associated with HF.

IMPACT

Five sites in the United States linked population-based healthcare data and vital records to establish surveillance network for identifying the factors which influence congenital heart disease (CHD) outcomes. Survivors of CHD frequently develop heart failure across the lifespan. Over 1 in 50 adolescent and 1 in 8 adult survivors of CHD have heart failure which is associated with increased mortality compared to CHD survivors without heart failure. Heart failure development is associated with potentially modifiable cardiovascular risk factors such as hypertension, coronary artery disease, and diabetes. Controlling modifiable cardiovascular risk factors may serve to lower the risk of heart failure and mortality in survivors of congenital heart disease of all ages.

Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease

PURPOSE OF REVIEW

The number of adult congenital heart disease (ACHD) patients presenting for consideration of heart transplantation continues to grow. Comprehensive pretransplant assessment and thoughtful patient selection are of critical importance to mitigate perioperative and posttransplant morbidity and mortality in this population.

RECENT FINDINGS

There is increasing evidence that patient outcomes after the onset of heart failure in the ACHD population are poor while overall transplant outcomes for ACHD patients have improved over time. Delineation of factors associated with better versus worse posttransplant outcomes is an area of ongoing research. Several studies have found that delayed patient referral, anatomic complexity and the presence of noncardiac organ dysfunction may increase peri-transplant and posttransplant risk.

SUMMARY

Pretransplant assessment and patient selection in ACHD patients should focus on mitigating perioperative and early posttransplant risk. Anatomic complexity, noncardiac organ dysfunction, and referral timing after the onset of heart failure can contribute to poor posttransplant outcomes and should inform patient selection.